Evidence map›Paper›PMID 35746935›Full record

ReviewFocus (American Psychiatric Publishing)2022

Psychiatric Applications of Repetitive Transcranial Magnetic Stimulation.

Katharine G Marder, Tracy Barbour, Stephen Ferber, Olanike Idowu, Amanda Itzkoff

Registry-linked trialAbstract readReview
In one paragraph

Review in Focus (American Psychiatric Publishing), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07527403 (Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07527403 recruitingnot on this mapstarted 2026, after this paper: background citation

Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder

TypeobservationalSponsorHospital Center Guillaume RégnierRan2026 to 2028Enrolled22ConditionsFunctional Neurological Disorder, Motor FNDArmstheta-burst rTMS (repetitive transcranial magnetic stimulation)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Investigating Cellular Magnetic Bioeffects Using Two-Channel, Two-Photon Autofluorescence Lifetime Microscopy.IEEE transactions on molecular, biological, and multi-scale communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katharine G MarderDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Tracy BarbourDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Stephen FerberDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Olanike IdowuDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Amanda ItzkoffDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcranial magnetic stimulation (TMS) is an increasingly popular noninvasive brain stimulation modality. In TMS, a pulsed magnetic field is used to noninvasively stimulate a targeted brain region. Repeated stimulation produces lasting changes in brain activity via mechanisms of synaptic plasticity similar to long-term potentiation. Local application of TMS alters activity in distant, functionally connected brain regions, indicating that TMS modulates activity of cortical networks. TMS has been approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder, obsessive-compulsive disorder, and smoking cessation, and a growing evidence base supports its efficacy in the treatment of other neuropsychiatric conditions. TMS is rapidly becoming part of the standard of care for treatment-resistant depression, where it yields response rates of 40%-60%. TMS is generally safe and well tolerated; its most serious risk is seizure, which occurs very rarely. This review aims to familiarize practicing psychiatrists with basic principles of TMS, including target localization, commonly used treatment protocols and their outcomes, and safety and tolerability. Practical considerations, including evaluation and monitoring of patients undergoing TMS, device selection, treatment setting, and insurance reimbursement, are also reviewed.

Indexed as

major depressive disorderobsessive-compulsive disorderRepetitive transcranial magnetic stimulationsmoking cessationTranscranial magnetic stimulation

Identifiers

PMID35746935
PMCPMC9063593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.